<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: hypogonadism</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'hypogonadism'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22hypogonadism%22&t=%22hypogonadism%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:38:58 +0100</lastBuildDate>
        <item>
            <title>The Lowdown On Low T And AndroGel Promotions</title>
            <link>http://www.medworm.com/index.php?rid=4976203&amp;cid=t_154957_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FIws0xix-Znw%2F</link>
            <description>A group of two dozen academics has lodged a formal complaint with the independent Pharmaceutical Advertising Advisory Board in Canada over a promotional campaign that Abbott Laboratories is running to promote its AndroGel testosterone gel, which was approved to treat hypogonadism. They cite a newspaper ad campaign, emails sent to physicians and the &amp;#8216;Low-T&amp;#8216; web site.
In their letter, the academics charge that Abbott is promoting AndroGel for unapproved uses, exaggerating implied effectiveness, potentially harming public health due to cardiovascular side effects associated with the gel and violating Canadian law by failing to disclose that the drugmaker is sponsoring various ads and communications aimed at consumers and physicians.
The ad &amp;#8220;has serious potential to lead to h...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4976203</comments>
            <pubDate>Tue, 28 Jun 2011 13:42:15 +0100</pubDate>
            <guid isPermaLink="false">4976203</guid>        </item>
        <item>
            <title>Prader-Willi Syndrome Classic Clinical Triad</title>
            <link>http://www.medworm.com/index.php?rid=4077186&amp;cid=t_154957_83_f&amp;fid=34856&amp;url=http%3A%2F%2Finsidesurgery.com%2F2010%2F10%2Fpraderwilli-syndrome-classic-clinical-triad%2F</link>
            <description>obesity, hypogonadism, mental retardation (Source: Inside Surgery)</description>
            <author>Inside Surgery</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4077186</comments>
            <pubDate>Sun, 17 Oct 2010 06:24:52 +0100</pubDate>
            <guid isPermaLink="false">4077186</guid>        </item>
        <item>
            <title>The Lowdown On Low Testosterone And AndroGel</title>
            <link>http://www.medworm.com/index.php?rid=3691111&amp;cid=t_154957_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FabPp1SIe2UY%2F</link>
            <description>A new study that finds low testosterone is much less common in older men than previously thought - and is closely identified with just nine specific symptoms - may cause physicians and patients to rethink their use of various elixirs. Take AndroGel, for instance. The salve is cleverly promoted on an unbranded web site called &amp;#8216;Is It Low T?,&amp;#8217; which features a quiz. The site lists various symptoms and risks purported to be associated with the condition, although some do not match what was noted in the study, which was published last week in The New England Journal of Medicine.
The study found that only 2 percent of men aged 40 to 80 suffer from the condition, which is also called male menopause, andropause or late-onset hypogonadism. The researchers measured testosterone levels in...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3691111</comments>
            <pubDate>Wed, 23 Jun 2010 19:20:49 +0100</pubDate>
            <guid isPermaLink="false">3691111</guid>        </item>
        <item>
            <title>New Book : Testosterone: A Man's Guide- by Nelson Vergel</title>
            <link>http://www.medworm.com/index.php?rid=3607757&amp;cid=t_154957_135_f&amp;fid=35262&amp;url=http%3A%2F%2Fsurvivinghiv.blogspot.com%2F2010%2F05%2Fnew-book-testosterone-mans-guide-by.html</link>
            <description>(Source: Nelson Vergel's HIV Blog)</description>
            <author>Nelson Vergel's HIV Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3607757</comments>
            <pubDate>Thu, 27 May 2010 16:46:00 +0100</pubDate>
            <guid isPermaLink="false">3607757</guid>        </item>
        <item>
            <title>Low Sex Drive? An Underarm Cream Will Do You</title>
            <link>http://www.medworm.com/index.php?rid=3370671&amp;cid=t_154957_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FHKCXYk7EypE%2F</link>
            <description>Looking to corner the market on improving your sex life, Eli Lilly has signed a deal with an Australian company called Acrux for the right to sell an underarm cream that can allegedly boost testerone levels. That&amp;#8217;s right. If you need a lift, you just lift your arm, shmear it on and off you go. Imagine the direct-to-consumer ads. However, this pertains to men over 45. The rest will have to use Cialis.
Results of a clinical trial released in September showed that, after four months, the Acrux cream helped 84 percent of patients achieve average blood levels of testosterone within the normal range. Acrux claims lowered testosterone affects 39 per cent of men over 45, with symptoms including decreased body mass and muscle strength, lowered libido and &amp;#8220;erectile quality,&amp;#8221; thinni...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3370671</comments>
            <pubDate>Tue, 16 Mar 2010 12:04:48 +0100</pubDate>
            <guid isPermaLink="false">3370671</guid>        </item>
        <item>
            <title>FDA denies approval to long acting testosterone injections</title>
            <link>http://www.medworm.com/index.php?rid=3056833&amp;cid=t_154957_135_f&amp;fid=35262&amp;url=http%3A%2F%2Fsurvivinghiv.blogspot.com%2F2009%2F12%2Ffda-denies-approval-to-long-acting.html</link>
            <description>(Source: Nelson Vergel's HIV Blog)</description>
            <author>Nelson Vergel's HIV Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3056833</comments>
            <pubDate>Thu, 03 Dec 2009 22:06:00 +0100</pubDate>
            <guid isPermaLink="false">3056833</guid>        </item>
        <item>
            <title>Comparative Analysis of HIV+ and HIV- Interaction with Testosterone on Bone Mineral Density</title>
            <link>http://www.medworm.com/index.php?rid=1926427&amp;cid=t_154957_135_f&amp;fid=35262&amp;url=http%3A%2F%2Fsurvivinghiv.blogspot.com%2F2008%2F11%2Fcomparative-analysis-of-hiv-and-hiv.html</link>
            <description>(Source: Nelson Vergel's HIV Blog)</description>
            <author>Nelson Vergel's HIV Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1926427</comments>
            <pubDate>Sat, 01 Nov 2008 17:25:00 +0100</pubDate>
            <guid isPermaLink="false">1926427</guid>        </item>
        <item>
            <title>Anabolic Steroid Induced Hypogonadism</title>
            <link>http://www.medworm.com/index.php?rid=1894949&amp;cid=t_154957_135_f&amp;fid=35262&amp;url=http%3A%2F%2Fsurvivinghiv.blogspot.com%2F2008%2F10%2Fanabolic-steroid-induced-hypogonadism.html</link>
            <description>(Source: Nelson Vergel's HIV Blog)</description>
            <author>Nelson Vergel's HIV Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1894949</comments>
            <pubDate>Tue, 21 Oct 2008 23:39:00 +0100</pubDate>
            <guid isPermaLink="false">1894949</guid>        </item>
        <item>
            <title>Indevus Pharmaceuticals Submits Nebido for FDA Approval</title>
            <link>http://www.medworm.com/index.php?rid=1001033&amp;cid=t_154957_97_f&amp;fid=35050&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F178819114%2Fthe_us_food_and_drug.html</link>
            <description>The U.S. Food and Drug Administration has accepted Indevus Pharmaceuticals Inc.&amp;#39;s (NASDAQ:IDEV)&amp;nbsp;&amp;nbsp;New Drug Application (NDA) for Nebido. The NDA was submitted August 28, 2007 and the target action date for the drug is June 27, 2008. Nebido is a long-acting testosterone injection for the treatment of hypogonadism. The NDA contained data from six clinical trials of over 3,000 injections as well as data from 260,000 injections worldwide. Hypogonadism is a medical condition in which there is an absence or reduction of testosterone in the testes. Reduced testosterone levels can lead to decreased sexual desire, muscle loss and weakness and the increased risk of osteoporosis. It is estimated that four to five million men in the U.S. suffer from hypogonadism and less than 10% are rece...</description>
            <author>PharmaGazette</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1001033</comments>
            <pubDate>Fri, 02 Nov 2007 17:15:44 +0100</pubDate>
            <guid isPermaLink="false">1001033</guid>        </item>
    </channel>
</rss>

